Eli Lilly Cuts Insulin Prices by 70 Percent, Caps Monthly Out-of-Pocket Costs at $35

Pharmaceutical manufacturer Eli Lilly and Company on Wednesday announced it would reduce the price of its most commonly prescribed insulins by 70% and expand its Insulin Value Program that limits patients’ monthly out-of-pocket costs to $35 or less.

Read More

Buddy Carter Commentary: Democrats’ Heads Are in the Clouds When It Comes to Lowering Drug Prices

Republicans have a plan to combat high prescription drug prices, without reverting to socialist price controls.

When I was a practicing pharmacist, I witnessed seniors trying to decide whether to pay for their medicine or pay for their groceries. I witnessed mothers crying because they couldn’t afford their children’s medicine.

Read More